TrueWealth LLC’s Exact Sciences EXAS Stock Holding History

TrueWealth LLC’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-219	Closed	-$13K	–	731
2020 Q1	$13K	Hold	219	–	–	0.01%	417
2019 Q4	$20K	Hold	219	–	–	0.01%	378
2019 Q3	$20K	Buy	+219	New	+$25K	0.01%	368

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

TrueWealth LLC's EXAS Position: Q2 2020 in Review

TrueWealth LLC sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 219 shares — an estimated $13K sold.

TrueWealth LLC first reported a position in EXAS in Q3 2019 and held it in 3 quarters. The position peaked at $20K in Q4 2019. 513 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

TrueWealth LLC reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
TrueWealth LLC sold 219 Exact Sciences shares in Q2 2020, an estimated $13K.
TrueWealth LLC first reported a position in Exact Sciences in Q3 2019 and held it in 3 quarters.
TrueWealth LLC's Exact Sciences position peaked at $20K in Q4 2019.
513 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.